Telomir Pharmaceuticals, Inc. Common Stock (TELO) quarterly balance sheet — complete assets, liabilities & equity history
| Total Current Assets | 5.79M | 7.34M | 7.4M | 829.61K | 491.19K | 1.32M | 1.04M | 2.1M | 3.5M | 435.23K | 236.31K | 96.07K |
| Cash & Short-Term Investments | 5.56M | 7.29M | 7.33M | 754.32K | 403K | 1.27M | 834.64K | 1.88M | 3.27M | 1.23K | 2.45K | 14.63K |
| Cash Only | 5.56M | 7.29M | 7.33M | 754.32K | 403K | 1.27M | 834.64K | 1.88M | 3.27M | 1.23K | 2.45K | 14.63K |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 130K | 0 | 130K | 130K | 0 |
| Days Sales Outstanding | - | - | - | - | - | - | - | - | - | - | - | - |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 102.89K | 0 |
| Days Inventory Outstanding | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Current Assets | 229.03K | 54.69K | 72.82K | 0 | 0 | 0 | 130K | 0 | 130K | 303.28K | 0 | 81.44K |
| Total Non-Current Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 4.34M | 5.08M | 5.83M |
| Property, Plant & Equipment | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Fixed Asset Turnover | - | - | - | - | - | - | - | - | - | - | - | - |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 4.34M | 5.08M | 5.83M |
| Total Assets | 5.79M | 7.34M | 7.4M | 829.61K | 491.19K | 1.32M | 1.04M | 2.1M | 3.5M | 4.77M | 5.32M | 5.92M |
| Asset Turnover | - | - | - | - | - | - | - | - | - | - | - | - |
| Asset Growth % | 1078.68% | 454.48% | 610.39% | -60.53% | -85.98% | -72.27% | -80.41% | -64.51% | - | 9696.36% | - | - |
| Total Current Liabilities | 827.31K | 1.43M | 422.81K | 348.39K | 652.29K | 680.97K | 599.91K | 534.15K | 486.55K | 1.34M | 3.14M | 2.03M |
| Accounts Payable | 0 | 0 | 329.38K | 254.96K | 558.86K | 587.54K | 506.48K | 393.81K | 221.56K | 707.19K | 496.03K | 845.58K |
| Days Payables Outstanding | - | - | - | - | - | - | - | - | - | - | - | - |
| Short-Term Debt | 0 | 0 | 93.43K | 93.43K | 93.43K | 93.43K | 93.43K | 0 | 7.9K | 101K | 1.34M | 487.91K |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 827.31K | 1.43M | 0 | 0 | 0 | 0 | 0 | 140.34K | 249.73K | 527.38K | 1.29M | 699.13K |
| Current Ratio | 7.00x | 5.14x | 17.51x | 2.38x | 0.75x | 1.94x | 1.74x | 3.93x | 7.20x | 0.33x | 0.08x | 0.05x |
| Quick Ratio | 7.00x | 5.14x | 17.51x | 2.38x | 0.75x | 1.94x | 1.74x | 3.93x | 7.20x | 0.33x | 0.04x | 0.05x |
| Cash Conversion Cycle | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Lease Obligations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Liabilities | 827.31K | 1.43M | 422.81K | 348.39K | 652.29K | 680.97K | 599.91K | 534.15K | 486.55K | 1.34M | 3.14M | 2.03M |
| Total Debt | 0 | 0 | 93.43K | 93.43K | 93.43K | 93.43K | 93.43K | 0 | 7.9K | 101K | 1.34M | 487.91K |
| Net Debt | -5.56M | -7.29M | -7.24M | -660.89K | -309.57K | -1.17M | -741.21K | -1.88M | -3.27M | 99.77K | 1.34M | 473.29K |
| Debt / Equity | - | - | 0.01x | 0.19x | - | 0.15x | 0.21x | - | 0.00x | 0.03x | 0.61x | 0.13x |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - |
| Interest Coverage | -829.75x | - | -402.77x | -3776.86x | - | - | - | - | -0.44x | -11.24x | -1.26x | -11.50x |
| Total Equity | 4.96M | 5.91M | 6.98M | 481.22K | -161.11K | 643.04K | 442.07K | 1.57M | 3.02M | 3.44M | 2.18M | 3.89M |
| Equity Growth % | 3180.1% | 819.6% | 1478.77% | -69.3% | -105.34% | -81.3% | -79.7% | -59.7% | 421.84% | 466.83% | - | - |
| Book Value per Share | 0.14 | 0.17 | 0.22 | 0.02 | -0.01 | 0.02 | 0.01 | 0.05 | 0.10 | 0.12 | 0.07 | 0.13 |
| Total Shareholders' Equity | 4.96M | 5.91M | 6.98M | 481.22K | -161.11K | 643.04K | 442.07K | 1.57M | 3.02M | 3.44M | 2.18M | 3.89M |
| Common Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Retained Earnings | -42M | -41.01M | -38.95M | -37.85M | -32.78M | -30.6M | -27.7M | -21.77M | -20.32M | -14.06M | -4.74M | -3.03M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |